 | • レポートコード：GIR-107A12010 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、α-メチルドパのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。α-メチルドパの種類別市場規模（経口、点滴、その他）、用途別市場規模（パーキンソニズム、肝性昏睡、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・α-メチルドパの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Icn Pharmaceuticals、Aa Pharma、Pro Doc Ltée、Laboratoires Confab、LGM Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、点滴、その他 ・用途別分析2016年-2026年：パーキンソニズム、肝性昏睡、その他 ・α-メチルドパの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・α-メチルドパのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・α-メチルドパのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・α-メチルドパの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・α-メチルドパの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The α-Methyldopa market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global α-Methyldopa size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global α-Methyldopa market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
α-Methyldopa market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Intravenous Drip
Other
Market segment by Application, can be divided into
Parkinsonism
Hepatic Coma
Others
Market segment by players, this report covers
Merck
Icn Pharmaceuticals
Aa Pharma
Pro Doc Ltée
Laboratoires Confab
LGM Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of α-Methyldopa
1.2 Classification of α-Methyldopa by Type
1.2.1 Overview: Global α-Methyldopa Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global α-Methyldopa Revenue Market Share by Type in 2020
1.2.3 Oral
1.2.4 Intravenous Drip
1.2.5 Other
1.3 Global α-Methyldopa Market by Application
1.3.1 Overview: Global α-Methyldopa Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Parkinsonism
1.3.3 Hepatic Coma
1.3.4 Others
1.4 Global α-Methyldopa Market Size & Forecast
1.5 Global α-Methyldopa Market Size and Forecast by Region
1.5.1 Global α-Methyldopa Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global α-Methyldopa Market Size by Region, (2016-2021)
1.5.3 North America α-Methyldopa Market Size and Prospect (2016-2026)
1.5.4 Europe α-Methyldopa Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific α-Methyldopa Market Size and Prospect (2016-2026)
1.5.6 South America α-Methyldopa Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa α-Methyldopa Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 α-Methyldopa Market Drivers
1.6.2 α-Methyldopa Market Restraints
1.6.3 α-Methyldopa Trends Analysis
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck α-Methyldopa Product and Solutions
2.1.4 Merck α-Methyldopa Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Merck Recent Developments and Future Plans
2.2 Icn Pharmaceuticals
2.2.1 Icn Pharmaceuticals Details
2.2.2 Icn Pharmaceuticals Major Business
2.2.3 Icn Pharmaceuticals α-Methyldopa Product and Solutions
2.2.4 Icn Pharmaceuticals α-Methyldopa Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Icn Pharmaceuticals Recent Developments and Future Plans
2.3 Aa Pharma
2.3.1 Aa Pharma Details
2.3.2 Aa Pharma Major Business
2.3.3 Aa Pharma α-Methyldopa Product and Solutions
2.3.4 Aa Pharma α-Methyldopa Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Aa Pharma Recent Developments and Future Plans
2.4 Pro Doc Ltée
2.4.1 Pro Doc Ltée Details
2.4.2 Pro Doc Ltée Major Business
2.4.3 Pro Doc Ltée α-Methyldopa Product and Solutions
2.4.4 Pro Doc Ltée α-Methyldopa Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pro Doc Ltée Recent Developments and Future Plans
2.5 Laboratoires Confab
2.5.1 Laboratoires Confab Details
2.5.2 Laboratoires Confab Major Business
2.5.3 Laboratoires Confab α-Methyldopa Product and Solutions
2.5.4 Laboratoires Confab α-Methyldopa Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Laboratoires Confab Recent Developments and Future Plans
2.6 LGM Pharma
2.6.1 LGM Pharma Details
2.6.2 LGM Pharma Major Business
2.6.3 LGM Pharma α-Methyldopa Product and Solutions
2.6.4 LGM Pharma α-Methyldopa Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 LGM Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global α-Methyldopa Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 α-Methyldopa Players Market Share
3.2.2 Top 10 α-Methyldopa Players Market Share
3.2.3 Market Competition Trend
3.3 α-Methyldopa Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global α-Methyldopa Revenue and Market Share by Type (2016-2021)
4.2 Global α-Methyldopa Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global α-Methyldopa Revenue Market Share by Application (2016-2021)
5.2 α-Methyldopa Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America α-Methyldopa Revenue by Type (2016-2026)
6.2 North America α-Methyldopa Revenue by Application (2016-2026)
6.3 North America α-Methyldopa Market Size by Country
6.3.1 North America α-Methyldopa Revenue by Country (2016-2026)
6.3.2 United States α-Methyldopa Market Size and Forecast (2016-2026)
6.3.3 Canada α-Methyldopa Market Size and Forecast (2016-2026)
6.3.4 Mexico α-Methyldopa Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe α-Methyldopa Revenue by Type (2016-2026)
7.2 Europe α-Methyldopa Revenue by Application (2016-2026)
7.3 Europe α-Methyldopa Market Size by Country
7.3.1 Europe α-Methyldopa Revenue by Country (2016-2026)
7.3.2 Germany α-Methyldopa Market Size and Forecast (2016-2026)
7.3.3 France α-Methyldopa Market Size and Forecast (2016-2026)
7.3.4 United Kingdom α-Methyldopa Market Size and Forecast (2016-2026)
7.3.5 Russia α-Methyldopa Market Size and Forecast (2016-2026)
7.3.6 Italy α-Methyldopa Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific α-Methyldopa Revenue by Type (2016-2026)
8.2 Asia-Pacific α-Methyldopa Revenue by Application (2016-2026)
8.3 Asia-Pacific α-Methyldopa Market Size by Region
8.3.1 Asia-Pacific α-Methyldopa Revenue by Region (2016-2026)
8.3.2 China α-Methyldopa Market Size and Forecast (2016-2026)
8.3.3 Japan α-Methyldopa Market Size and Forecast (2016-2026)
8.3.4 South Korea α-Methyldopa Market Size and Forecast (2016-2026)
8.3.5 India α-Methyldopa Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia α-Methyldopa Market Size and Forecast (2016-2026)
8.3.7 Australia α-Methyldopa Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America α-Methyldopa Revenue by Type (2016-2026)
9.2 South America α-Methyldopa Revenue by Application (2016-2026)
9.3 South America α-Methyldopa Market Size by Country
9.3.1 South America α-Methyldopa Revenue by Country (2016-2026)
9.3.2 Brazil α-Methyldopa Market Size and Forecast (2016-2026)
9.3.3 Argentina α-Methyldopa Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa α-Methyldopa Revenue by Type (2016-2026)
10.2 Middle East & Africa α-Methyldopa Revenue by Application (2016-2026)
10.3 Middle East & Africa α-Methyldopa Market Size by Country
10.3.1 Middle East & Africa α-Methyldopa Revenue by Country (2016-2026)
10.3.2 Turkey α-Methyldopa Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia α-Methyldopa Market Size and Forecast (2016-2026)
10.3.4 UAE α-Methyldopa Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global α-Methyldopa Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global α-Methyldopa Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market α-Methyldopa Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global α-Methyldopa Revenue (USD Million) by Region (2016-2021)
Table 5. Global α-Methyldopa Revenue Market Share by Region (2021-2026)
Table 6. Merck Corporate Information, Head Office, and Major Competitors
Table 7. Merck Major Business
Table 8. Merck α-Methyldopa Product and Solutions
Table 9. Merck α-Methyldopa Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Icn Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Icn Pharmaceuticals Major Business
Table 12. Icn Pharmaceuticals α-Methyldopa Product and Solutions
Table 13. Icn Pharmaceuticals α-Methyldopa Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Aa Pharma Corporate Information, Head Office, and Major Competitors
Table 15. Aa Pharma Major Business
Table 16. Aa Pharma α-Methyldopa Product and Solutions
Table 17. Aa Pharma α-Methyldopa Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pro Doc Ltée Corporate Information, Head Office, and Major Competitors
Table 19. Pro Doc Ltée Major Business
Table 20. Pro Doc Ltée α-Methyldopa Product and Solutions
Table 21. Pro Doc Ltée α-Methyldopa Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Laboratoires Confab Corporate Information, Head Office, and Major Competitors
Table 23. Laboratoires Confab Major Business
Table 24. Laboratoires Confab α-Methyldopa Product and Solutions
Table 25. Laboratoires Confab α-Methyldopa Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. LGM Pharma Corporate Information, Head Office, and Major Competitors
Table 27. LGM Pharma Major Business
Table 28. LGM Pharma α-Methyldopa Product and Solutions
Table 29. LGM Pharma α-Methyldopa Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global α-Methyldopa Revenue (USD Million) by Players (2019-2021)
Table 31. Global α-Methyldopa Revenue Share by Players (2019-2021)
Table 32. Breakdown of α-Methyldopa by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. α-Methyldopa Players Head Office, Products and Services Provided
Table 34. α-Methyldopa Mergers & Acquisitions in the Past Five Years
Table 35. α-Methyldopa New Entrants and Expansion Plans
Table 36. Global α-Methyldopa Revenue (USD Million) by Type (2016-2021)
Table 37. Global α-Methyldopa Revenue Share by Type (2016-2021)
Table 38. Global α-Methyldopa Revenue Forecast by Type (2021-2026)
Table 39. Global α-Methyldopa Revenue by Application (2016-2021)
Table 40. Global α-Methyldopa Revenue Forecast by Application (2021-2026)
Table 41. North America α-Methyldopa Revenue by Type (2016-2021) & (USD Million)
Table 42. North America α-Methyldopa Revenue by Type (2021-2026) & (USD Million)
Table 43. North America α-Methyldopa Revenue by Application (2016-2021) & (USD Million)
Table 44. North America α-Methyldopa Revenue by Application (2021-2026) & (USD Million)
Table 45. North America α-Methyldopa Revenue by Country (2016-2021) & (USD Million)
Table 46. North America α-Methyldopa Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe α-Methyldopa Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe α-Methyldopa Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe α-Methyldopa Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe α-Methyldopa Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe α-Methyldopa Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe α-Methyldopa Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific α-Methyldopa Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific α-Methyldopa Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific α-Methyldopa Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific α-Methyldopa Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific α-Methyldopa Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific α-Methyldopa Revenue by Region (2021-2026) & (USD Million)
Table 59. South America α-Methyldopa Revenue by Type (2016-2021) & (USD Million)
Table 60. South America α-Methyldopa Revenue by Type (2021-2026) & (USD Million)
Table 61. South America α-Methyldopa Revenue by Application (2016-2021) & (USD Million)
Table 62. South America α-Methyldopa Revenue by Application (2021-2026) & (USD Million)
Table 63. South America α-Methyldopa Revenue by Country (2016-2021) & (USD Million)
Table 64. South America α-Methyldopa Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa α-Methyldopa Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa α-Methyldopa Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa α-Methyldopa Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa α-Methyldopa Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa α-Methyldopa Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa α-Methyldopa Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. α-Methyldopa Picture
Figure 2. Global α-Methyldopa Revenue Market Share by Type in 2020
Figure 3. Oral
Figure 4. Intravenous Drip
Figure 5. Other
Figure 6. α-Methyldopa Revenue Market Share by Application in 2020
Figure 7. Parkinsonism Picture
Figure 8. Hepatic Coma Picture
Figure 9. Others Picture
Figure 10. Global α-Methyldopa Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global α-Methyldopa Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global α-Methyldopa Revenue Market Share by Region (2016-2026)
Figure 13. Global α-Methyldopa Revenue Market Share by Region in 2020
Figure 14. North America α-Methyldopa Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe α-Methyldopa Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific α-Methyldopa Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America α-Methyldopa Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa α-Methyldopa Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. α-Methyldopa Market Drivers
Figure 20. α-Methyldopa Market Restraints
Figure 21. α-Methyldopa Market Trends
Figure 22. Merck Recent Developments and Future Plans
Figure 23. Icn Pharmaceuticals Recent Developments and Future Plans
Figure 24. Aa Pharma Recent Developments and Future Plans
Figure 25. Pro Doc Ltée Recent Developments and Future Plans
Figure 26. Laboratoires Confab Recent Developments and Future Plans
Figure 27. LGM Pharma Recent Developments and Future Plans
Figure 28. Global α-Methyldopa Revenue Share by Players in 2020
Figure 29. α-Methyldopa Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players α-Methyldopa Revenue Market Share in 2020
Figure 31. Global Top 10 Players α-Methyldopa Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global α-Methyldopa Revenue Share by Type in 2020
Figure 34. Global α-Methyldopa Market Share Forecast by Type (2021-2026)
Figure 35. Global α-Methyldopa Revenue Share by Application in 2020
Figure 36. Global α-Methyldopa Market Share Forecast by Application (2021-2026)
Figure 37. North America α-Methyldopa Sales Market Share by Type (2016-2026)
Figure 38. North America α-Methyldopa Sales Market Share by Application (2016-2026)
Figure 39. North America α-Methyldopa Revenue Market Share by Country (2016-2026)
Figure 40. United States α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe α-Methyldopa Sales Market Share by Type (2016-2026)
Figure 44. Europe α-Methyldopa Sales Market Share by Application (2016-2026)
Figure 45. Europe α-Methyldopa Revenue Market Share by Country (2016-2026)
Figure 46. Germany α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific α-Methyldopa Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific α-Methyldopa Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific α-Methyldopa Revenue Market Share by Region (2016-2026)
Figure 54. China α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America α-Methyldopa Sales Market Share by Type (2016-2026)
Figure 61. South America α-Methyldopa Sales Market Share by Application (2016-2026)
Figure 62. South America α-Methyldopa Revenue Market Share by Country (2016-2026)
Figure 63. Brazil α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa α-Methyldopa Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa α-Methyldopa Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa α-Methyldopa Revenue Market Share by Country (2016-2026)
Figure 68. Turkey α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE α-Methyldopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
世界の静脈内免疫グロブリン療法市場 2021：企業別、地域別、種類・用途別 The Intravenous Immune Globulin Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- 世界の経口高分子製剤市場 2021：企業別、地域別、種類・用途別 The Oral Macromolecule Formulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の経口固形剤形製剤市場 2021：企業別、地域別、種類・用途別 The Oral Solid Dosage Pharmaceutical Formulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の経口徐放性ドラッグデリバリー技術市場 2021：企業別、地域別、種類・用途別 The Oral Controlled Release Drug Delivery Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 世界の口腔疾患治療市場 2021：企業別、地域別、種類・用途別 The Oral Diseases Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…